Drug Use And Addiction Research Programs federal funding in FY2026

Drug Use And Addiction Research Programs and FY2026 as a USAspending pair

Drug Use and Addiction Research in FY2026 obligated $223,455,385.24 on USAspending.gov. Keep both keys in the citation: the CFDA title Drug Use And Addiction Research Programs and the fiscal year 2026. 1.9% of $11,966,347,937.16 is arithmetic on two packet facts, not a ranking of fiscal years as winners or losers. The catalog title is DRUG USE AND ADDICTION RESEARCH PROGRAMS. Basic versus clinical versus services-research lines are unpublished inside this yearlyTrend cell. FY2026 is a small share of a multi-year extract.

Read /programs/93.279/ (CFDA 93.279) for the program rollup, /fiscal-years/2026/ (FY2026 federal spending) for the year rollup, /programs/ (All programs) for every CFDA hub, and /ties/ (All spending ties) for the rest of the join list. Do not add those pages into $223,455,385.24. Recipients are unpublished. Two hundred nineteen FY2026 award records against a 5,019-row program extract is an early-year research slice, not a named-lab roster. Competing renewals add rows.

Program coding for Drug Use and Addiction Research

USAspending labels CFDA 93.279 as Drug Use And Addiction Research Programs. That code produced $223,455,385.24 when crossed with fiscal year 2026. The program-wide hub does not require a FY2026 filter. The year hub does not require this CFDA. Only this tie applies both filters. The catalog title is DRUG USE AND ADDICTION RESEARCH PROGRAMS. Basic versus clinical versus services-research lines are unpublished inside this yearlyTrend cell. FY2026 is a small share of a multi-year extract. FY2026 figures can still move in later USAspending ingests.

The program extract-wide obligation total is $11,966,347,937.16 across 5,019 award records. FY2026 is 1.9% of that book. Other fiscal-year rows for CFDA 93.279 are separate cells. Do not fold /programs/ into this join as if every CFDA were this one. Keep 93.279.

FY2026 as an early Drug Use and Addiction Research slice

FY2026 on USAspending.gov is a federal fiscal year, not a calendar year and not a state fiscal year. $223,455,385.24 is the Drug Use And Addiction Research Programs slice of that year in this extract, not the government-wide FY2026 total. FY2026 figures can still move in later USAspending ingests. Prefer /fiscal-years/2026/ if the live year table moved. Outlays are unpublished.

The year hub /fiscal-years/2026/ (FY2026 federal spending) rolls up every program that year in the index, not only Drug Use And Addiction Research Programs. Reading $223,455,385.24 as all FY2026 federal obligations would over-read this cell. The join is one CFDA inside one fiscal year, not a Budget Appendix score. Do not add Federal Election Commission contribution totals to $223,455,385.24.

219 FY2026 awards are not 219 laboratories

219 is the FY2026 award-record count published on this pair. 5,019 is the program-extract award-record count across years. Dividing $223,455,385.24 by 5,019 would mix a one-year dollar total with a multi-year row count, so this page does not publish that ratio as a typical award. Unique recipients are unpublished. Two hundred nineteen FY2026 award records against a 5,019-row program extract is an early-year research slice, not a named-lab roster. Competing renewals add rows.

Commitment totals versus cash paid

Budget justifications, program evaluation reports, and press releases answer other questions. They are not the source of this cell. If a chart mixes a SAMHSA treatment twin, a clinic ranking, or a named-institute list with CFDA 93.279 in FY2026, the chart has left this join. Principal investigators, institutions, and study titles are unpublished on this packet.

Keep the citation narrow: CFDA 93.279 and fiscal year 2026 on USAspending.gov, obligations only, with no invented recipients. Principal investigators, institutions, and study titles are unpublished on this packet.

Questions

How much did Drug Use And Addiction Research Programs show in federal obligations in FY2026?

USAspending.gov records $223,455,385.24 in Drug Use And Addiction Research Programs obligations for FY2026 (CFDA 93.279) across 219 awards. That is an obligation aggregate for the pair, not an outlay and not the program-wide $11,966,347,937.16.

Is Drug Use and Addiction Research FY2026 cash already paid to labs?

No. $223,455,385.24 is a yearlyTrend obligation sum, not an outlay. Payments from the Treasury can lag or differ. This packet has no outlay total for Drug Use And Addiction Research Programs in FY2026. Original filings remain on USAspending.gov.

Do 219 awards mean 219 addiction studies?

No. 219 is the FY2026 award-record count on this pair, not a published unique-recipient census. The program extract lists 5,019 awards across years. Modifications can add rows. Original filings remain on USAspending.gov. Keep both the CFDA number and the fiscal year in the citation.

Which pages parent Drug Use And Addiction Research Programs and FY2026?

The CFDA 93.279 hub is the program parent. The FY2026 federal-spending hub is the year parent. All programs lists CFDA hubs. All spending ties lists other pairs. Prefer those tables after later ingests; this page quotes Drug Use And Addiction Research Programs × FY2026 at $223,455,385.24.